Telehealth platform Hims & Hers swings to Q2 net loss as margin pressure offsets revenue growth

Hims & Hers Health

10/08/2026 21:15

Overview
US health platform's Q2 revenue rose 38% yr/yr, beating analyst expectations
Company posted Q2 net loss of $86.3 mln, compared to net income a year earlier
Full-year 2026 revenue guidance raised to $3.1 bln-$3.3 bln on strong domestic and international growth
Shares of the company were down about 6% in extended trading

Outlook
Company raises 2026 revenue guidance to $3.1 bln-$3.3 bln
Company updates 2026 adj EBITDA outlook to $275 mln-$325 mln
Hims & Hers expects Q3 revenue of $880 mln-$900 mln

Result Drivers
INTERNATIONAL EXPANSION - Co said international business grew more than 17-fold, boosted by the Eucalyptus acquisition
SUBSCRIBER GROWTH - Subscribers rose 19% yr/yr to nearly 2.9 mln, supporting revenue growth
HIGHER REVENUE PER SUBSCRIBER - Monthly revenue per average subscriber increased 21% yr/yr to $92
ACQUISITION, RESTRUCTURING CHARGES - Gross margin contracts to 64% from 76% a year earlier on acquisition and restructuring charges

Company press release: ID:nBw9HG4lca

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$753 mln
$699.89 mln (12 Analysts)
Q2 Loss Per Share
 
$0.37
 
Q2 Net Loss
 
$86.30 mln
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 12 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Hims & Hers Health, Inc. is $28.50, about 9.8% below its August 7 closing price of $31.59
The stock recently traded at 112 times the next 12-month earnings vs. a P/E of 47 three months ago

Reuters Recommended Reads
Aug 10 - Surgery Partners Q2 revenue beats on growth in same-facility segment
Aug 9 - RadNet raises outlook as Q2 revenue jumps 25%, adjusted EPS beats estimates 
Aug 10 - Eli Lilly's weight-loss pill secures first European nod in Britain

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)